E. Eylemer Mocan Et Al. , "Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients.," Anti-cancer drugs , vol.35, no.2, pp.190-194, 2024
Eylemer Mocan, E. Et Al. 2024. Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients.. Anti-cancer drugs , vol.35, no.2 , 190-194.
Eylemer Mocan, E., Yekedüz, E., Karataş, G., Yazgan, S. C., Köksoy, E. B., Çay Şenler, F., ... Utkan, G.(2024). Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients.. Anti-cancer drugs , vol.35, no.2, 190-194.
Eylemer Mocan, Eda Et Al. "Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients.," Anti-cancer drugs , vol.35, no.2, 190-194, 2024
Eylemer Mocan, Eda E. Et Al. "Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients.." Anti-cancer drugs , vol.35, no.2, pp.190-194, 2024
Eylemer Mocan, E. Et Al. (2024) . "Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients.." Anti-cancer drugs , vol.35, no.2, pp.190-194.
@article{article, author={Eda Eylemer Mocan Et Al. }, title={Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients.}, journal={Anti-cancer drugs}, year=2024, pages={190-194} }